NASDAQ : LFCR
Lifecore Biomedical, Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 6.4 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 242.26M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 242.26M |
| Enterprise Value | 368.52M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 37.85M |
| Shares Outstanding | 37.85M |
| Shares Change (YoY) | +1.63% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 3.75% |
| Owned by Institutions (%) | 27.38% |
| Float | 19.34M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.87 |
| Forward PS | 1.92 |
| PB Ratio | 7.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 38.89 |
| P/OCF Ratio | 19.28 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.85 |
| EV / EBITDA | 44.71 |
| EV / EBIT | n/a |
| EV / FCF | 59.15 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.49 |
| Quick Ratio | 2.18 |
| Debt / Equity | 4.22 |
| Debt / EBITDA | 16.83 |
| Debt / FCF | 23.07 |
| Interest Coverage | -0.05 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -0.76% |
| Return on Capital Employed (ROCE) | -0.60% |
| Weighted Average Cost of Capital (WACC) | 11.61% |
| Revenue Per Employee | $338,913 |
| Profits Per Employee | -$90,323 |
| Employee Count | 382 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 577,714 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.98 |
| 52-Week Price Change | -9.35% |
| 50-Day Moving Average | 5.42 |
| 200-Day Moving Average | 5.51 |
| Relative Strength Index (RSI) | 65.46 |
| Average Volume (20 Days) | 575,104 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.80M |
| Short Previous Month | 2.48M |
| Short % of Shares Out | 4.76% |
| Short % of Float | 9.32% |
| Short Ratio (days to cover) | 2.92 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 129.46M |
| Gross Profit | 40.61M |
| Operating Income | -1.26M |
| Pretax Income | -30.21M |
| Net Income | -34.50M |
| EBITDA | 8.24M |
| EBIT | -1.26M |
| Loss Per Share | -$0.93 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 17.47M |
| Total Debt | 143.73M |
| Net Cash | -126.26M |
| Net Cash Per Share | -$3.34 |
| Equity (Book Value) | 34.06M |
| Book Value Per Share | -0.38 |
| Working Capital | 58.72M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 12.57M |
| Capital Expenditures | -6.34M |
| Depreciation & Amortization | 9.50M |
| Net Borrowing | -4.29M |
| Free Cash Flow | 6.23M |
| FCF Per Share | $0.16 |
Margins
| Measure | Value |
|---|
| Gross Margin | 31.37% |
| Operating Margin | -0.97% |
| Pretax Margin | -23.34% |
| Profit Margin | -23.78% |
| EBITDA Margin | 6.37% |
| EBIT Margin | -0.97% |
| FCF Margin | 4.81% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.63% |
| Shareholder Yield | -1.63% |
| Earnings Yield | -14.46% |
| FCF Yield | 2.57% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $6.28 |
| Price Target Difference | -1.88% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 6.35% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.29 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |